Pharmacogenomics and the Placebo Response.

Area of Science:

• Pharmacology
• Genetics
• Clinical Trials

Background:

• Clinical trials increasingly fail to demonstrate superiority over placebo responses.
• This failure hinders the development of novel treatments, impacting pharmaceutical companies.
• Variability in placebo response is potentially linked to genetic factors.

Purpose of the Study:

• To investigate the genomic underpinnings of the placebo response.
• To explore the concept of the

Main Methods:

• Review of recent evidence on placebo response variability.
• Analysis of genetic factors influencing placebo effects.

Main Results:

• Genetic variation may contribute to individual differences in placebo response.
• Understanding the

Conclusions:

• A deeper understanding of the genetic basis of placebo effects is warranted.
• This knowledge could enable more effective utilization of placebos in clinical trials and drug development.
• Investigating the